- Home
- CWBC vs AQST Comparison
CWBC vs AQST Comparison
Compare CWBC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWBC
- AQST
- Stock Information
- Founded
- CWBC 1989
- AQST 2004
- Country
- CWBC United States
- AQST United States
- Employees
- CWBC N/A
- AQST N/A
- Industry
- CWBC Major Banks
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- CWBC Finance
- AQST Health Care
- Exchange
- CWBC Nasdaq
- AQST Nasdaq
- Market Cap
- CWBC 395.8M
- AQST 390.4M
- IPO Year
- CWBC 1996
- AQST 2018
- Fundamental
- Price
- CWBC $20.75
- AQST $5.97
- Analyst Decision
- CWBC Buy
- AQST Strong Buy
- Analyst Count
- CWBC 3
- AQST 7
- Target Price
- CWBC $21.67
- AQST $10.29
- AVG Volume (30 Days)
- CWBC 50.2K
- AQST 3.5M
- Earning Date
- CWBC 10-23-2025
- AQST 11-03-2025
- Dividend Yield
- CWBC 2.32%
- AQST N/A
- EPS Growth
- CWBC 95.72
- AQST N/A
- EPS
- CWBC 1.39
- AQST N/A
- Revenue
- CWBC $132,829,000.00
- AQST $44,132,000.00
- Revenue This Year
- CWBC $30.64
- AQST N/A
- Revenue Next Year
- CWBC $6.58
- AQST $51.50
- P/E Ratio
- CWBC $14.83
- AQST N/A
- Revenue Growth
- CWBC 55.84
- AQST N/A
- 52 Week Low
- CWBC $15.57
- AQST $2.12
- 52 Week High
- CWBC $22.89
- AQST $6.43
- Technical
- Relative Strength Index (RSI)
- CWBC 47.55
- AQST 63.42
- Support Level
- CWBC $20.37
- AQST $5.47
- Resistance Level
- CWBC $21.40
- AQST $5.93
- Average True Range (ATR)
- CWBC 0.40
- AQST 0.36
- MACD
- CWBC -0.10
- AQST 0.02
- Stochastic Oscillator
- CWBC 24.49
- AQST 69.67
About CWBC Community West Bancshares
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.